Want to join the conversation?
$SLB 2Q15 PR: Geographic Revenue: North America $2,361MM vs. $3,222MM in 2Q14. LatAm $1,537MM vs. $1,648MM in 2Q14. Europe/CIS/Africa $2,413MM vs. $2,538MM in 2Q14. MEA $2,575MM vs. $2,703MM in 2Q14. Operating cash flow was $2,314MM. As of June 30, 2015, cash and short-term investments were $7,274MM vs. $7,501MM as of Dec. 31, 2014.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?